VENTOLIN HFA Drug Patent Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
When do Ventolin Hfa patents expire, and when can generic versions of Ventolin Hfa launch?
Ventolin Hfa is a drug marketed by Glaxosmithkline and is included in one NDA. There are two patents protecting this drug.
This drug has twenty-nine patent family members in seventeen countries.
The generic ingredient in VENTOLIN HFA is albuterol sulfate. There are thirty-eight drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the albuterol sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ventolin Hfa
A generic version of VENTOLIN HFA was approved as albuterol sulfate by SUN PHARM INDUSTRIES on December 5th, 1989.
Summary for VENTOLIN HFA
International Patents: | 29 |
US Patents: | 2 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 7 |
Raw Ingredient (Bulk) Api Vendors: | 80 |
Clinical Trials: | 49 |
Patent Applications: | 6,071 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for VENTOLIN HFA |
Drug Sales Revenues: | Drug sales revenues for VENTOLIN HFA |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for VENTOLIN HFA |
What excipients (inactive ingredients) are in VENTOLIN HFA? | VENTOLIN HFA excipients list |
DailyMed Link: | VENTOLIN HFA at DailyMed |


See drug prices for VENTOLIN HFA

Recent Clinical Trials for VENTOLIN HFA
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Hat Yai Medical Education Center | Phase 3 |
Nationwide Children's Hospital | Phase 4 |
Ohio State University | Phase 4 |
Pharmacology for VENTOLIN HFA
Drug Class | beta2-Adrenergic Agonist |
Mechanism of Action | Adrenergic beta2-Agonists |
US Patents and Regulatory Information for VENTOLIN HFA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glaxosmithkline | VENTOLIN HFA | albuterol sulfate | AEROSOL, METERED;INHALATION | 020983-001 | Apr 19, 2001 | BX | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||
Glaxosmithkline | VENTOLIN HFA | albuterol sulfate | AEROSOL, METERED;INHALATION | 020983-001 | Apr 19, 2001 | BX | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for VENTOLIN HFA
International Patents for VENTOLIN HFA
See the table below for patents covering VENTOLIN HFA around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 1287820 | Compositions d'aĆ©rosol (Aerosol compositions) | ⤷ Try a Trial |
Japan | 3908269 | ⤷ Try a Trial | |
Spain | 2216800 | ⤷ Try a Trial | |
United Kingdom | 9721875 | ⤷ Try a Trial | |
Austria | 171865 | ⤷ Try a Trial | |
Cyprus | 2008 | Pharmaceutical aerosol formulation | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |